September 5, 2025
NHIA submitted comments to the DME MAC medical directors regarding their proposed local coverage determination (LCD) for external infusion pumps (EIPs). DL33794 would expand Medicare Part B coverage for blinatumomab (Blimcyto®, Amgen) for certain indications. NHIA agrees that the expanded access meets the EIP qualifying criteria, but registered concerns about the fragmentation between the DME-infused drug benefit and the HIT services benefit and its lack of sufficient coverage for pharmacy services. NHIA also asked for clarification regarding provider’s ability to use non-proprietary infusion pumps to administer foscarbidopa/foslevodopa (Vyalev™, Abbvie) in the event of a supply chain issue.
The National Home Infusion Foundation (NHIF) is proud to announce Barbara Petroff, MS, RPh, BCSCP, CAC, CSPP, IgCP, FNHIA, FASHP as the recipient of the 2026 Women in Leadership Award.
The National Home Infusion Association (NHIA) is proud to announce that Melissa Leone, RN, BSN, FNHIA has been selected as the recipient of the 2026 Gene Graves Lifetime Achievement Award.
The National Home Infusion Association (NHIA) is proud to announce its 2026-2027 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization.
